December 28, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jordan Nimitz
| Re: | MDxHealth SA Registration Statement on Form F-3 File No. 333-268885 |
Acceleration Request
Requested Date: December 30, 2022
Requested Time: 4:30 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MDxHealth SA hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement to 4:30 p.m., Eastern Time, on December 30, 2022, or as soon thereafter as practicable or at such later time as the Company may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Please confirm once the Registration Statement has been declared effective by calling Mark Busch of K&L Gates LLP at (704) 331-7440. Please also contact him should you have any questions.
| /s/ Michael McGarrity | |
| Michael McGarrity | |
| Chief Executive Officer |
cc:
Mark R. Busch, Esq.
K&L Gates LLP
